IGF2BP2 and cancer: mir-1193 has been found to inhibit the proliferation and invasion of cancer cells by directly acting on transmembrane 9 superfamily member 3 (TM9SF3) and insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) (44, 45).